Voyager Therapeutics VYGR
NASDAQ VYGR
$2.04 -0.15 (-6.85%)
As of: Oct 21, 2026 · 11:12 AM EDT

Voyager Therapeutics (VYGR) Operating Interest Expenses (2014)

Updated

Voyager Therapeutics' Operating Interest Expenses was $9.75 million in FY2015, up 400.3% from $1.95 million in FY2014.

Analysis

Voyager Therapeutics (VYGR) Operating Interest Expenses (2014) Analysis & Trends

  • Per Business Quant data, Operating Interest Expenses in earlier years was $1.95 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Eli Lilly 1,129.91 Bn 1,098.50 Bn 19.71 Bn -
2 Johnson & Johnson 613.69 Bn 532.22 Bn 17.26 Bn -
3 AbbVie 503.05 Bn 476.16 Bn 12.70 Bn -
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn -
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn -
6 Astrazeneca 261.30 Bn 234.99 Bn 12.86 Bn -
7 Amgen 235.86 Bn 191.25 Bn 7.24 Bn -
8 Gilead Sciences 190.51 Bn 164.71 Bn 6.22 Bn -
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn -
10 Voyager Therapeutics 123.52 Mn -539.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 195,000.00
Sep 30, 2014 349,000.00
API Access

Voyager Therapeutics Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=VYGR&period=max&api_key=YOUR_API_KEY